Article Name North America
Developed with PacBio's PureTarget technology, the new test enhances identification of complex DNA repeat expansions to support accurate diagnosis and care for patients with neurological disorders
30th July, 2025
Strategic alliance enhances in-home screening with advanced molecular diagnostics, AI-driven insights, and flexible testing options to improve outcomes for patients and underserved communities.
29th July, 2025
New Metrix Filovirus Panel to deliver 30-minute, lab-quality results from blood samples in remote and point-of-care settings—marking a pivotal step in global outbreak preparedness.
29th July, 2025
Designed for seamless remote use, the ‘Anywhere powered by Linus Health™’ platform brings early detection of cognitive decline to payers, pharma, wellness providers, and consumers—anytime, anywhere.
29th July, 2025
Breakthrough findings for QyScore® and QyPredict® highlight enhanced accuracy in brain segmentation and early identification of cognitive decline, paving the way for improved clinical trials and patient outcomes in Alzheimer’s disease.
29th July, 2025
Launched at AAIC 2025, the ultra-sensitive assays aim to improve early detection, disease monitoring, and biomarker discovery in neurodegenerative research.
28th July, 2025
Collaboration aims to improve access to advanced lab testing through at-home services, supporting earlier detection and personalized care delivery.
28th July, 2025
Collaboration aims to streamline cardiac data workflows and enhance clinical decision-making through seamless EHR integration.
28th July, 2025
New solution aims to enhance workflow efficiency, image quality, and accessibility in busy hospitals and diagnostic centers worldwide.
28th July, 2025
Breakthrough technology aims to transform hematology diagnostics by combining full-field imaging and AI-driven analysis for faster, more accurate results.
25th July, 2025
Simplified Process Aims to Boost Participation in Colorectal Cancer Screening and Improve Early Detection Rates
25th July, 2025
Clinical research highlights the potential of Hyperfine’s portable brain imaging system to improve early diagnosis and expand access to neuroimaging in underserved dementia populations.
25th July, 2025
Seamless integration enables enhanced cardiometabolic care by delivering real-time glucose insights to clinicians across Tenovi’s remote patient monitoring platform.
24th July, 2025
Collaboration aims to expand access to innovative, non-opioid interventions for knee OA, enhancing early treatment options and improving patient outcomes.
24th July, 2025
Clinical milestone underscores BD’s growing role in self-administered drug delivery and expands real-world evaluation of its on-body injection platform for large-volume biologics.
24th July, 2025
The integration enhances multimodal brain monitoring by streamlining EEG data access, visualization, and clinical decision-making in critical care environments.
23rd July, 2025
Landmark integration of in vitro organ-on-a-chip and computational modeling marks a pivotal advancement in disease simulation, drug testing, and personalized medicine.
23rd July, 2025
Danish multicenter study confirms clinical utility of genomic test in identifying low-risk stage I–II melanoma patients, advancing precision in surgical decision-making
22nd July, 2025
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer